Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure

Table 4 Adverse events during follow-up

Patients (gender, age)	Months in follow-up before termination	Cause of termination
Male, 52	9	Relapsing angina*, CCS III
Male, 70	11	Withdrawal from follow-up
Male, 64	9	Relapsing angina*, CCS III
Male, 71	10	Relapsing angina*, CCS III
Male, 66	9	Relapsing angina*, CCS IV
Male, 62	8	Relapsing angina*, CCS III
Male, 73	14	Relapsing angina*, CCS III
Male, 53	12	Relapsing angina*, CCS III
Male, 57	10	Relapsing angina*, CCS III
Male, 74	20	Death due to pneumonia and cardiac failure
Male, 71	10	Relapsing angina*, CCS III
Male, 71	4	Death of unknown causes
Female, 79	14	Death due to amyloidosis
Male, 71	21	Relapsing angina*, CCS III

* = Patients with relapsing angina pectoris in need of further therapy during the follow-up. CCS = Canadian Cardiovascular Society classification.

ISSN: 1471-2261